Characteristics and Treatments of Patients with G3 Gastroenteropancreatic Neuroendocrine Tumors (G3-NET) and Neuroendocrine Carcinoma (NEC): A European Multicenter Retrospective Study


Introduction: Data on G3-NET and NEC are limited. No standard therapy following platinum-etoposide failure is established and first-line therapy in G3-NET is not codified.

Aim(s): To evaluate clinical and pathological characteristics of diagnosis, therapies and outcome in NEC G3.

Materials and methods: Retrospective study of patients (pts) with G3-NET and NEC from five European centers diagnosed between 01/01/00 and 01/09/13.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Heetfeld M, Rinke A, Borbath I, Crespo G, Olsen I,

Keywords: gastrointestinal cancer, neuroendocrine carcinoma, grade 3 NET, Ki-67, chemotherapy,

To read the full abstract, please log into your ENETS Member account.